{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:48:45Z","timestamp":1793256525143,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Peripheral ulcerative keratitis (PUK) is a group of inflammatory corneal ulcers with stromal thinning and peripheral localization. Amniotic membranes (AM) are used for their anti-inflammatory and healing properties. A freeze-drying process now allows maintaining the AM viable for a long time at room temperature without altering its physical, biological, and morphologic characteristics. The effectiveness of spongy freeze-dried amniotic membrane (FD-AM) graft with multimodal imaging in the management of severe corneal thinning PUK has not been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 67-year-old Caribbean man histologically diagnosed with ulcerative colitis, was referred to our tertiary eye care center for a deep nasal juxtalimbal ulcer of the left eye. He was treated with topical steroids and antibiotics, methylprednisolone pulses, and oral prednisone. Due to continuous stromal thinning with 100\u00a0\u03bcm of residual corneal thickness, the decision was made to perform surgery. Conjunctival resection, inlay and overlay spongy FD-AM (Visio Amtrix\u00ae S, Tissue Bank of France, FR) were performed to preserve globe integrity. Despite tapering off oral steroids, PUK developed in the fellow eye on the 2 months follow-up. Treatment with human monoclonal antibody against tumor necrosis factor-alpha was initiated to control the active underlying inflammation. Six months following surgery, the ulcer was healed and corneal thickness in front of the former ulceration was measured at 525\u00a0\u03bcm on anterior segment-optical coherence tomography. Confocal microscopy confirmed the integration of the amniotic membrane between the corneal epithelium and the anterior stroma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Transplantation of FD-AM with a spongy layer was associated with restoration of normal corneal thickness in the PUK area. It seems to be a safe, effective, and easily accessible solution for the surgical management of PUK with impending perforation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-023-03129-3","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T14:03:51Z","timestamp":1695305031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Freeze-dried amniotic membrane graft with a spongy layer in bilateral peripheral ulcerative keratitis: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Clara","family":"Bertret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Leveziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Knoeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Georgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Jamart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacim","family":"Bouheraoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Borderie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"4","key":"3129_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","volume":"33","author":"A Galor","year":"2007","unstructured":"Galor A, Thorne JE. Scleritis and Peripheral Ulcerative Keratitis. Rheum Dis Clin N Am nov. 2007;33(4):835\u201354.","journal-title":"Rheum Dis Clin N Am nov"},{"issue":"1","key":"3129_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archopht.120.1.15","volume":"120","author":"M de la Sainz","year":"2002","unstructured":"de la Sainz M. Ocular characteristics and Disease Associations in Scleritis-Associated Peripheral Keratopathy. Arch Ophthalmol 1 janv. 2002;120(1):15.","journal-title":"Arch Ophthalmol 1 janv"},{"issue":"1","key":"3129_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1167\/iovs.03-0752","volume":"45","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Sterilized. Freeze-dried amniotic membrane: a useful substrate for Ocular Surface Reconstruction. Invest Ophthalmol Vis Sci 1 janv. 2004;45(1):93\u20139.","journal-title":"Invest Ophthalmol Vis Sci 1 janv"},{"issue":"2","key":"3129_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3129\/i10-116","volume":"46","author":"ME Gregory","year":"2011","unstructured":"Gregory ME, Spiteri-Cornish K, Hegarty B, Mantry S, Ramaesh K. Combined amniotic membrane transplant and anterior stromal puncture in painful bullous keratopathy: clinical outcome and confocal microscopy. Can J Ophthalmol avr. 2011;46(2):169\u201374.","journal-title":"Can J Ophthalmol avr"},{"key":"3129_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7298026","volume":"2017","author":"Y Cao","year":"2017","unstructured":"Cao Y, Zhang W, Wu J, Zhang H, Zhou H. Peripheral ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment. J Ophthalmol. 2017;2017:1\u201312.","journal-title":"J Ophthalmol"},{"issue":"1","key":"3129_CR6","first-page":"66","volume":"9","author":"J Tauber","year":"1990","unstructured":"Tauber J, de la Sainz M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea janv. 1990;9(1):66\u201373.","journal-title":"Cornea janv"},{"issue":"9","key":"3129_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00384-007-0275-1","volume":"22","author":"S Yilmaz","year":"2007","unstructured":"Yilmaz S, Aydemir E, Maden A, Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis sept. 2007;22(9):1027\u201330.","journal-title":"Int J Colorectal Dis sept"},{"issue":"9","key":"3129_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1136\/bjophthalmol-2017-310671","volume":"102","author":"HM Timlin","year":"2018","unstructured":"Timlin HM, Hall HN, Foot B, Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the british Ophthalmological Surveillance Unit. Br J Ophthalmol sept. 2018;102(9):1298\u2013302.","journal-title":"Br J Ophthalmol sept"},{"issue":"2","key":"3129_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5500\/wjt.v4.i2.111","volume":"4","author":"C Malhotra","year":"2014","unstructured":"Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111.","journal-title":"World J Transplant"},{"issue":"6","key":"3129_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/ICO.0000000000001919","volume":"38","author":"J Yin","year":"2019","unstructured":"Yin J, Singh RB, Karmi RA, Yung A, Yu M, Dana R. Outcomes of cyanoacrylate tissue adhesive application in corneal thinning and perforation. Cornea juin. 2019;38(6):668\u201373.","journal-title":"Cornea juin"},{"issue":"8","key":"3129_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/ICO.0000000000001955","volume":"38","author":"N Sharma","year":"2019","unstructured":"Sharma N, Singhal D, Maharana PK, Vajpayee RB. Tuck-In Tenon Patch Graft in corneal perforation. Cornea ao\u00fbt. 2019;38(8):951\u20134.","journal-title":"Cornea ao\u00fbt"},{"issue":"2","key":"3129_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4103\/ijo.IJO_2035_21","volume":"70","author":"V Anitha","year":"2022","unstructured":"Anitha V, Ghorpade A, Ravindran M. A modified tenons sling annular graft for advanced peripheral ulcerative keratitis with an hourglass cornea. Indian J Ophthalmol f\u00e9vr. 2022;70(2):655\u20137.","journal-title":"Indian J Ophthalmol f\u00e9vr"},{"key":"3129_CR13","doi-asserted-by":"crossref","unstructured":"Kamra D, Chappadi K, Dudam R, Murthy SI. Management of simultaneous bilateral immune-mediated peripheral ulcerative keratitis. Eur J Ophthalmol 29 d\u00e9c 2022;11206721221149066.","DOI":"10.1177\/11206721221149066"},{"issue":"2","key":"3129_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10561-020-09821-8","volume":"21","author":"P Nazari Hashemi","year":"2020","unstructured":"Nazari Hashemi P, Chaventre F, Bisson A, Gueudry J, Boyer O, Muraine M. Mapping of proteomic profile and effect of the spongy layer in the human amniotic membrane. Cell Tissue Bank juin. 2020;21(2):329\u201338.","journal-title":"Cell Tissue Bank juin"},{"key":"3129_CR15","unstructured":"Gain P et al. (2018) The OBSERV Platform: study of a new lyophilized amniotic membrane \u2013 Poster EVER 2018. 27\u201330 septembre \u2013 Nice."},{"issue":"4","key":"3129_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1755-3768.2008.01261.x","volume":"87","author":"MT Rodr\u00edguez-Ares","year":"2009","unstructured":"Rodr\u00edguez-Ares MT, L\u00f3pez-Valladares MJ, Touri\u00f1o R, Vieites B, Gude F, Silva MT, et al. Effects of lyophilization on human amniotic membrane. Acta Ophthalmol (Copenh) juin. 2009;87(4):396\u2013403.","journal-title":"Acta Ophthalmol (Copenh) juin"},{"key":"3129_CR17","doi-asserted-by":"crossref","unstructured":"Memmi B, Leveziel L, Knoeri J, Lecl\u00e8re A, Ribes O, Despiaux MC et al. Freeze-dried Versus Cryopreserved amniotic membranes in corneal ulcers treated by overlay transplantation: a case-control study. Cornea. 29 juin 2021;.","DOI":"10.1097\/ICO.0000000000002794"},{"issue":"7","key":"3129_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ophtha.2012.01.021","volume":"119","author":"M Ang","year":"2012","unstructured":"Ang M, Mehta JS, Sng CCA, Htoon HM, Tan DTH. Indications, outcomes, and risk factors for failure in tectonic keratoplasty. Ophthalmol Juill. 2012;119(7):1311\u20139.","journal-title":"Ophthalmol Juill"},{"issue":"2","key":"3129_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10792-011-9430-3","volume":"31","author":"P Neri","year":"2011","unstructured":"Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A. Adalimumab (Humira\u2122): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Int Ophthalmol avr. 2011;31(2):165\u201373.","journal-title":"Int Ophthalmol avr"},{"issue":"26","key":"3129_CR20","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1097\/MD.0000000000000176","volume":"93","author":"V Huerva","year":"2014","unstructured":"Huerva V, Ascaso FJ, Grzybowski A. Infliximab for Peripheral Ulcerative Keratitis Treatment. Med (Baltimore) d\u00e9c. 2014;93(26):e176.","journal-title":"Med (Baltimore) d\u00e9c"},{"key":"3129_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/203819","volume":"2012","author":"CL Kraus","year":"2012","unstructured":"Kraus CL, Culican SM. Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease. Int J Rheumatol. 2012;2012:1\u20136.","journal-title":"Int J Rheumatol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03129-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-03129-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03129-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:16:06Z","timestamp":1700583366000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-03129-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-03129-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Helsinski\u2019s declaration was respected. Written informed consent was obtained from the patient to participate in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained to publish this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"387"}}